US FDA approves Springworks’ genetic disorder drug

(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Springworks Therapeutics’ drug to treat a type of rare genetic disorder that causes tumors to grow on nerves throughout the body.

(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)